SCHEMBL14533530

SCHEMBL14533530

COC(=O)[C@H](COC(C)(C)C)NCl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRN P28799 1/20 0.44
▸ SORT1 Q99523 1/20 0.44
▸ MAPK1 P28482 2/20 0.39
▸ BACE1 P56817 1/20 0.38
▸ KDM4E B2RXH2 3/20 0.34
▸ CACNA1H O95180 1/20 0.33
▸ KEAP1 Q14145 1/20 0.33
▸ KLK5 Q9Y337 1/20 0.33
▸ LIPG Q9Y5X9 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CFD P00746 1/20 0.32
▸ MAPT P10636 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ TAS1R3 Q7RTX0 1/20 0.31
▸ TAS1R1 Q7RTX1 1/20 0.31
▸ CTSL P07711 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14211341 1.00 GRN (0.44) GRNSORT1MAPK1BACE1KDM4E
SCHEMBL13993198 0.87 GRN (0.43) GRNSORT1MAPK1BACE1ALDH1A1
SCHEMBL28528204 0.84 MAPK1 (0.41) GRNSORT1MAPK1BACE1KDM4E
SCHEMBL1361481 0.84 MAPK1 (0.41) GRNSORT1MAPK1BACE1KDM4E
SCHEMBL2763844 0.78 MAPK1 (0.36) GRNSORT1MAPK1BACE1KDM4E
SCHEMBL16508862 0.78 MAPK1 (0.48) GRNSORT1MAPK1BACE1ALDH1A1
SCHEMBL12171679 0.78 MAPK1 (0.48) GRNSORT1MAPK1BACE1ALDH1A1
SCHEMBL31473151 0.78 GRN (0.40) GRNSORT1MAPK1BACE1KDM4E
SCHEMBL23805193 0.77 CTSK (0.46) KLK5CA1CA2CTSLCTSS
SCHEMBL8372342 0.77 CTSK (0.46) KLK5CA1CA2CTSLCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070112200-A1 Non-racemic hexafluoreleucine,and methods of making and using it TRUSTEES OF TUFTS COLLEGE (US) 2007-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112200-A1 Non-racemic hexafluoreleucine,and methods of making and using it CRYZ, FABP5, FAU GRN 2437/4885SORT1 2878/4885MAPK1 3370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback